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THE evolution ofthe transplanted suprarenal tumour ofA x C rats is different
in the two sexes; the tumour grows more rapidly in intact females than in
intact males, and females survive a shorter time than males (Table II in Iglesias
and Mardones, 1958). The problem of the dependence of tumour growth on
the gonads is of considerable interest. A similar dependence has been found
also with other tumours: the transplantable ovarian tumour in mice (Miihlbock,
1952) and the transplantable ovarian tumour in our A x C strain of rats (Iglesias
and Mardones, 1956a, 1956b). In the present paper results of a more detailed
study of the dependence of the transplantable suprarenal tumour of A x C
rats on the gonads will be given. The influence of gonadal steroids, of cortisone
and of ACTH also has been studied. All experiments were made with the sub-
cutaneous transplantation of a suprarenal tumour of the second transplant
generation. The latent period was determined by palpation. The " volume"
of the tumour is the product of three diameters measured with the caliper.
Results are summarized in Table I.
TABLE I.-Twenty-four Animals with Subcutaneous Inoculation of Suprarenal Tumour
Receiving Gonodal Steroids or Cortisone, Compared with 48 Intact and Castrated
Animals with Tumours but Not Receiving Steroids. Seven Animals Receiving ACTH.
Weight
"Volumiie " Weight Number Weight of uterus
tumour of tumour of of the and seminal
Latent Sur- at 86 at animals 2 supra- vesicle
Steroid period vival days necropsy with renals (mg.)
Groups* (aug./day) (days) (days) (cm.3) (g.) metast. (mg.) Uterus
1. Fem., intact . 58 156 83 . 29 . 1 . 138 . 163
2. Fem., int. castr.t . . 52 175 . 78 34 . 2 12-5 . 142
3. Fem., castr. . . - 67 . 216 1-0 . 35 0 . 13-3 . 80
4. Fem., castr. . . Oestrad. (53) 85 147 0 7 16 . 3 . 26-0 416
5. Fem., castr. . Progest. (151) . 67 . 221 0 44 . 34 . 2 12- 7 80
6. Fem., castr. . Cortis. acet. (644). . 52 . 162 17 . 18 . 1 . 116 . 108
Sem. ves.t
Right-left.
7. Male, intact - 64 235 0-6 41 . 3 . 10-6 . 33-29§
8 Male, int. castr.t - 68 . 228 0 4 29 2 11-7 40-32
9. Male, castr. . 66 . 223 0 . 38 2 11-6 . 15-13
Uterus
10. Fem., castr. . . ACTH . 177 384 ± . 25 . 4 . 13-0 . 66
* Eight animals in each group, with the exception of group 10 with 7 animals only.
t Castrated at 86 days after inoculation.
4 Right seminal vesicle with content; left seminal vesicle without content.
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Influence of the gonads
As seen from Table I the difference as to growth in intact females and males is
very considerable. At say 86 days the volume of the tumour in intact females is
many times greater than in intact males (compare groups 1 and 7). When
comparing the evolution ofthe tumour in intact and castrated females it becomes
fully evident that growth of the suprarenal tumour is greatly enhanced by the
ovary (compare 1 and 3). On the contrary, there is no such influence ofthe male
gonad (compare 7 and 9).
It is of great interest to compare these results with those obtained with the
transplantable ovarian tumour in the same strain. Growth of the ovarian
tumour is enhanced by the presence both of the ovary and the testicle (Iglesias
and Mardones, 1956a); on the contrary, only the ovary is capable of enhancing
the growth of the suprarenal tumour. But there is still another difference which
is apparently fundamental: the differential response ofthe ovarian and suprarenal
tumour of the same strain to gonadal steroids.
Influence of gonadal steroids
Steroids were absorbed from pellets implanted subcutaneously one day after
inoculation. Absorption per day was determined from the loss of weight of the
pellet. As seen from Table I, group 4, an average of 53 ,tg./day of oestradiol
was absorbed. With quantities of oestradiol so large as 53 ,ug./day which were
sufficient to cause uterine growth and suprarenal hyperplasia, the latent period
was even longer than in castrated females without oestrogen (compare 3 and 4);
at 86 days the tumour was still the same size as in castrated females not receiving
oestrogen. Indeed survival was considerably shortened when oestradiol was
given. At the first glance one might argue that oestradiol had some share in
reconditioning malignancy of the suprarenal tumour, as is the case with the
ovarian tumour (Iglesias and Mardones, 1956b). However, the shorter survival
was most probably due to a pituitary tumour present in these females induced
by the administered oestradiol. That death was not due to the suprarenal
tumour is shown also by the following experiment: 8 castrated males not inocu-
lated with the suprarenal tumour but receiving the same quantity of oestrogen
survived only 162 (159-183) days, i.e. not more than the 8 inoculated castrated
females receiving oestrogen (group 4); a large pituitary tumour similar to that
ofthe females was found in all the 8 males. Thus, it seems reasonable to conclude
that the growth of our suprarenal tumour is not enhanced by oestrogen and that
malignancy of the suprarenal tumour is not reconditioned, contrary to what has
been found with the transplantable ovarian tumour in the same strain. The same
negative resultwas obtainedinthepresent experiments withprogesterone (compare
groups 3 and 5). Growth ofthe transplantable ovarian tumour of the same strain
was greatly stimulated byprogesterone (Table I, group 7, in Iglesias andMardones,
1956b). The objection could be made that in the experiments with the ovarian
tumour much larger quantities of progesterone were given; but the amount
absorbed in the present work was still very considerable (group 5 in Table I).
Differential behaviour of the transplantable ovarian and suprarenal tumour of the
same strain
Growth of both tumours depends on the ovary. The differential behaviour
can be summarized in the following statement: whereas the influence of the
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ovary on the evolution ofthe ovarian tumour and on the reconditioning of malig-
nancy is due to the ovarian steroids, or to a steroid derived from these, recon-
ditioning of the malignant growth of the suprarenal tumour in castrated females
which is not obtained by gonadal steroids, is seemingly due to some other factor
linked with the ovary so far unsuspected and unknown to us.
Comparative behaviour of the transplantable spontaneous suprarenal tumour and
suprarenal tumours induced by castration
Both oestrogen and androgen are known to inhibit in mice the growth of
suprarenal tumours induced by castration (Woolley, 1950). The final weight
of our transplanted suprarenal tumour was smaller with oestrogen than with the
presence of the ovary (Table I; compare groups 1 and 4). This difference
cannot be explained by shorter survival as survival was not longer in intact
females than in animals with oestrogen. The difference in the final weight of
the tumour in groups 1 and 4 might be due to one of the three alternatives: (1)
lack of the enhancing influence of the ovary, or (2) inhibition of growth as with
oestrogen in animals with induced suprarenal tumours, or (3) shorter survival due
to oestrogen.
Experiments with corticoids and A.C.T.H.-With cortisone (group 6) a certain
amount of inhibition might have been produced, the final weight of the tumour
being considerably smaller than in other groups with the same survival. But
here again, as with oestradiol, the smaller final weight of the tumour might be
due to lack of the enhancing influence of the gonad. Cortisone did not increase
the frequency ofmetastases which occurs with other tumours (Agosin et al., 1952).
Desoxycorticosterone is known to inhibit the growth of induced suprarenal
tumours in rats and mice (Houssay, Higgins and Bennett, 1951; Ambrad-
Dominguez and Cardeza, 1953). Our own experience with this corticoid is not
yet sufficient for us to venture any conclusion. Decidedly conflicting though
at the same time stimulating results were obtained with the administration of
corticotrophin. ACTH of Fredriksborg Chemical Laboratories was used and
4 I.U. were injected every second day; a total of 27 injections were given. An
astonishing prolongation of the latent period and of survival took place. The
animals survived 10 to 181 months with an average of 13 months. We are unable
to explain these results. It would be worth while to extend the experimental
study of the action of corticotrophin on the suprarenal tumour.
SUMMARY
Growth of the transplantable spontaneous suprarenal tumour of A x C rats
is slowed down and survival of the animals is prolonged by ovariectomy.
Growth of the tumour in intact males and also survival of the latter is similar
to that in castrated females, and growth in males is not influenced by castration.
Metastases are more frequent in males than in females, due probably to longer
survival ofmales.
The influence of the ovary on the growth of the tumour is apparently not due
to oestrogen or progesterone.
With ACTH, growth of the tumour was inhibited: the latent period and
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